BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05223673-completion@plaintrial.com
DTSTAMP:20261111T202221Z
DTSTART;VALUE=DATE:20230621
SUMMARY:Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluri
 dine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants 
 With Previously Treated Metastatic Colorectal Cancer — estimated complet
 ion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05223673
URL:https://plaintrial.com/trial/NCT05223673
END:VEVENT
END:VCALENDAR